Published in J Biol Chem on March 11, 2010
Characterizing intermolecular interactions that initiate native-like protein aggregation. Biophys J (2012) 0.84
Understanding protein aggregation from the view of monomer dynamics. Mol Biosyst (2012) 0.83
Mechanisms of amyloid formation revealed by solution NMR. Prog Nucl Magn Reson Spectrosc (2015) 0.80
The Tubular Sheaths Encasing Methanosaeta thermophila Filaments Are Functional Amyloids. J Biol Chem (2015) 0.79
Deletional protein engineering based on stable fold. PLoS One (2012) 0.77
Studying interactions by molecular dynamics simulations at high concentration. J Biomed Biotechnol (2012) 0.76
Equilibrium Ensembles for Insulin Folding from Bias-Exchange Metadynamics. Biophys J (2017) 0.75
Delicate balance between functionally required flexibility and aggregation risk in a β-rich protein. Biochemistry (2013) 0.75
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42
Primary structure effects on peptide group hydrogen exchange. Proteins (1993) 10.79
Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med (Berl) (2003) 5.15
Amyloid formation by globular proteins under native conditions. Nat Chem Biol (2009) 3.72
Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta (2004) 3.69
Average protein density is a molecular-weight-dependent function. Protein Sci (2004) 2.62
Altered flexibility in the substrate-binding site of related native and engineered high-alkaline Bacillus subtilisins. J Mol Biol (1999) 2.13
Protein quality in bacterial inclusion bodies. Trends Biotechnol (2006) 2.02
The Yin and Yang of protein folding. FEBS J (2005) 1.68
Insights into acylphosphatase structure and catalytic mechanism. Cell Mol Life Sci (1997) 1.32
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol (2005) 1.19
Aggregation of the Acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation. J Biol Chem (2004) 1.11
Expression, purification, and characterization of acylphosphatase muscular isoenzyme as fusion protein with glutathione S-transferase. Protein Expr Purif (1995) 1.09
Structure, conformational stability, and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus. Proteins (2006) 0.99
Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation. Biophys J (2006) 0.96
Stabilization of a native protein mediated by ligand binding inhibits amyloid formation independently of the aggregation pathway. J Med Chem (2006) 0.94
The degree of structural protection at the edge beta-strands determines the pathway of amyloid formation in globular proteins. J Am Chem Soc (2008) 0.92
A model for the aggregation of the acylphosphatase from Sulfolobus solfataricus in its native-like state. Biochim Biophys Acta (2008) 0.89
Measurement of amyloid fibril length distributions by inclusion of rotational motion in solution NMR diffusion measurements. Angew Chem Int Ed Engl (2008) 0.88
Exploring the mechanism of formation of native-like and precursor amyloid oligomers for the native acylphosphatase from Sulfolobus solfataricus. Structure (2006) 0.88
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol (2005) 3.18
Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A (2013) 2.96
Prediction of aggregation-prone regions in structured proteins. J Mol Biol (2008) 2.56
A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol (2010) 2.48
Systematic in vivo analysis of the intrinsic determinants of amyloid Beta pathogenicity. PLoS Biol (2007) 2.35
Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol (2004) 2.14
Protein folding: defining a "standard" set of experimental conditions and a preliminary kinetic data set of two-state proteins. Protein Sci (2005) 1.91
Prefibrillar amyloid aggregates could be generic toxins in higher organisms. J Neurosci (2006) 1.89
Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci U S A (2004) 1.83
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep (2007) 1.78
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation. Structure (2005) 1.63
Insight into the structure of amyloid fibrils from the analysis of globular proteins. PLoS Comput Biol (2006) 1.55
The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci (2002) 1.44
Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem Biol (2012) 1.41
Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem (2006) 1.33
Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. Proc Natl Acad Sci U S A (2005) 1.31
cGMP-binding prepares PKG for substrate binding by disclosing the C-terminal domain. J Mol Biol (2007) 1.27
Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J (2005) 1.25
Amino acid empirical contact energy definitions for fold recognition in the space of contact maps. BMC Bioinformatics (2003) 1.24
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. J Mol Biol (2008) 1.24
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma. Br J Haematol (2011) 1.20
Evidence for a mechanism of amyloid formation involving molecular reorganisation within native-like precursor aggregates. J Mol Biol (2005) 1.19
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. Curr Opin Struct Biol (2008) 1.14
Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging (2008) 1.14
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers. Proc Natl Acad Sci U S A (2012) 1.13
Prediction of amyloid aggregation in vivo. EMBO Rep (2011) 1.11
Aggregation of the Acylphosphatase from Sulfolobus solfataricus: the folded and partially unfolded states can both be precursors for amyloid formation. J Biol Chem (2004) 1.11
The projection analysis of NMR chemical shifts reveals extended EPAC autoinhibition determinants. Biophys J (2012) 1.10
Sequence and structural determinants of amyloid fibril formation. Acc Chem Res (2006) 1.07
The catalytic site of glutathione peroxidases. Antioxid Redox Signal (2008) 1.07
Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci (2006) 1.07
Reversible post-traumatic bilateral extensive restricted diffusion of the brain. A case study and review of the literature. Brain Inj (2009) 1.05
Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallin. J Biol Chem (2013) 1.04
Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state. Biophys J (2005) 1.03
Investigating the effects of mutations on protein aggregation in the cell. J Biol Chem (2004) 1.01
Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility. Proc Natl Acad Sci U S A (2011) 1.01
Aggregation propensity of the human proteome. PLoS Comput Biol (2008) 1.00
Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. J Mol Biol (2003) 1.00
Conformational properties of the aggregation precursor state of HypF-N. J Mol Biol (2008) 1.00
Structure, conformational stability, and enzymatic properties of acylphosphatase from the hyperthermophile Sulfolobus solfataricus. Proteins (2006) 0.99
Monitoring the process of HypF fibrillization and liposome permeabilization by protofibrils. J Mol Biol (2004) 0.99
Nature and significance of the interactions between amyloid fibrils and biological polyelectrolytes. Biochemistry (2006) 0.99
Reversal of protein aggregation provides evidence for multiple aggregated States. J Mol Biol (2004) 0.99
Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide. Biophys J (2010) 0.99
Properties of some variants of human beta2-microglobulin and amyloidogenesis. J Biol Chem (2003) 0.98
Amyloid fibril formation and disaggregation of fragment 1-29 of apomyoglobin: insights into the effect of pH on protein fibrillogenesis. J Mol Biol (2007) 0.97
Relative influence of hydrophobicity and net charge in the aggregation of two homologous proteins. Biochemistry (2003) 0.97
Equilibrium collapse and the kinetic 'foldability' of proteins. Biochemistry (2002) 0.97
Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation. Biophys J (2006) 0.96
Constraint Logic Programming approach to protein structure prediction. BMC Bioinformatics (2004) 0.96
Kinetic analysis of amyloid formation in the presence of heparan sulfate: faster unfolding and change of pathway. J Biol Chem (2009) 0.96
Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem (2010) 0.96
The EMILIN/Multimerin family. Front Immunol (2012) 0.96
Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR. J Biol Chem (2009) 0.95
The distribution of residues in a polypeptide sequence is a determinant of aggregation optimized by evolution. Biophys J (2007) 0.95
Amyloid formation by the model protein muscle acylphosphatase is accelerated by heparin and heparan sulphate through a scaffolding-based mechanism. J Biochem (2009) 0.94
Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res (2006) 0.94
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci (2005) 0.94
Stabilization of a native protein mediated by ligand binding inhibits amyloid formation independently of the aggregation pathway. J Med Chem (2006) 0.94
Amyloid formation from HypF-N under conditions in which the protein is initially in its native state. J Mol Biol (2005) 0.93
Role of dynamics in the autoinhibition and activation of the exchange protein directly activated by cyclic AMP (EPAC). J Biol Chem (2011) 0.93
SIRT1 gene expression upon genotoxic damage is regulated by APE1 through nCaRE-promoter elements. Mol Biol Cell (2013) 0.92
The degree of structural protection at the edge beta-strands determines the pathway of amyloid formation in globular proteins. J Am Chem Soc (2008) 0.92
Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem Biol (2014) 0.92
Comparison of the folding processes of distantly related proteins. Importance of hydrophobic content in folding. J Mol Biol (2003) 0.91
Micro-heterogeneity and aggregation in beta2-microglobulin solutions: effects of temperature, pH, and conformational variant addition. Eur Biophys J (2006) 0.91
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med (2011) 0.90
Scoring predictive models using a reduced representation of proteins: model and energy definition. BMC Struct Biol (2007) 0.90
Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation. J Am Chem Soc (2008) 0.89
The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the alpha4beta1 integrin. J Biol Chem (2008) 0.89
Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils. PLoS One (2011) 0.89